US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 13.040
  • +1.330+11.36%
Close Nov 29 13:00 ET
  • 13.010
  • -0.030-0.23%
Post 16:54 ET
1.53BMarket Cap-7808P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
37.34M
44.76M
+7.42M
Beat Est.
-2.02%
+17.44%
+19.86%
EPS
-0.42
-0.33
+0.09
Beat Est.
+42.47%
+54.79%
+21.41%
Analyst Rating
Strong Buy

Nov 30, 2024

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 56.264M--
--2024/Q4-- / 54.670M--
Nov 6, 20242024/Q344.755M / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 56.264M--
--2024/Q4-- / 54.670M--
Nov 6, 20242024/Q344.755M / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--

Unlock Free Earnings Estimates

Arcutis Biotherapeutics Earnings Reports

  • Arcutis Biotherapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:12 ET

  • Arcutis Biotherapeutics | 8-K: Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update

    Nov 6 16:07 ET

  • Arcutis Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:18 ET

  • Arcutis Biotherapeutics | 8-K: Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update

    Aug 14 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-6.28%